Use of topical tranexamic acid in primary total hip arthroplasty. Efficiency and safety. Our experience. / Utilización del ácido tranexámico tópico en la artroplastia total primaria de cadera. Eficacia y seguridad. Nuestra experiencia.

BACKGROUND AND AIM: Intravenous tranexamic acid has been shown to reduce bleeding and the need for transfusions in total hip arthroplasty, although it has a theoretical risk of producing thromboembolic phenomena. Recently some papers have been published using the topical application of tranexamic acid, but the ideal administration protocol has not yet been clearly defined. The aim of this paper was to demonstrate that our protocol of topical tranexamic acid is effective and safe. MATERIALS AND METHODS: Prospective data collection from a case series of 80 primary hip arthroplasties, in which the following topical tranexamic acid protocol is used: 1.5 grams diluted to a total volume of 60ml were administered, applying 20ml in the acetabular bed, 20ml in the femoral canal and 20ml through the Redon drain, keeping it closed for 20minutes. RESULTS: Eighty patients were operated. Preoperative haemoglobin 14.26g / dL; preoperative haematocrit 42.39%. An average loss of 2.74g / dL of haemoglobin and 8% of haematocrit was obtained. Eleven percent of the patients required transfusion, of whom 67% had known previous anaemia; only 3 patients without prior anaemia required transfusion (4%). There were no thromboembolic complications in our series. CONCLUSIONS: The use of topical tranexamic acid was safe and effective in primary total hip arthroplasty, reducing the need for blood transfusion compared to that described in the literature in untreated patients.

Calcific tendinopathy of the shoulder with intraosseous extension: experience with arthroscopic treatment and review of the literature. / Tendinitis calcificante de hombro con extensión intraósea: experiencia con el tratamiento artroscópico y revisión de la literatura.

BACKGROUND AND AIM: Calcific tendinitis of the rotator cuff is a common cause of shoulder pain. The aim of the present study was to show a rare presentation of calcific tendinopathy of the shoulder, the intraosseous extension, which can be mistaken for a bone tumour or an infectious disease. MATERIAL AND METHODS: Two clinical cases of calcific tendinopathy of the shoulder with intraosseous extension and a review of the literature are presented. RESULTS: Cortical erosion, osteolytic lesion in the greater tuberosity and perilesional oedema were observed in both cases. Good results were achieved with shoulder arthroscopy including lesion debridement and reinsertion of the tendon in the greater tuberosity with an anchor. CONCLUSIONS: In the presence of an osteolytic lesion with perilesional oedema in the greater tuberosity, the intraosseous expansion of a calcifying tendinopathy should be included in the differential diagnosis. In our cases the arthroscopic treatment was successful.

[Results of polyurethane implant for persistent knee pain after partial meniscectomy with a minimum of two years follow-up]. / Resultados de un implante de poliuretano para el tratamiento del dolor persistente de rodilla tras meniscectomía parcial con un mínimo de dos años de seguimiento.

PURPOSE: To present the results of a polyurethane meniscal scaffold implant in 10 patients with persistent pain after meniscectomy. METHODS: Prospective, descriptive study of ten patients who underwent arthroscopic implantation of a polyurethane meniscal scaffold. Functional, MRI, and radiography assessment was performed pre-operatively and at 6-months, 1-year, and a final follow-up at a minimum of two years. Clinical evaluation included Lysholm score, KOOS and VAS. The MRI morphology and signal intensity of the implant were evaluated according to the criteria of Genovese et al. RESULTS: Statistically significant differences were found between the mean Lysholm score before surgery (63.5 points), and that at 6 months (76.8 points) (p=.001), one year (83.3 points) (p<.001) and final follow-up (84.4 points) (p<.001). KOOS showed significant differences between before surgery (64.23 points), 6 months (73.66 points) (p=.001), one year (81.39 points) (p<.001) and final follow-up (83.34 points) (p<.001). The mean values for VAS were 5.7 points in the pre-operative evaluation, 3.6 points at 6 months-follow-up (p<.001), 1.9 points at one year (p<.001), and 1.9 points at final follow-up (p<.001). Radiology showed degenerative changes in one case. In MRI, the size of the implant and the intensity of the MRI signal gradually decreased, but it never changed to that of a normal meniscus. CONCLUSION: A significant improvement was found in all the clinical parameters 24 months after the surgery, except in one patient who underwent furher surgery. The scaffold reduced its size and but never achieved an MRI image similar to that of a normal meniscus. The procedure proved to be safe and useful for the treatment of persistent pain after meniscectomy.

Resultados de un implante de poliuretano para el tratamiento del dolor persistente de rodilla tras meniscectomía parcial con un mínimo de dos años de seguimiento / Results of polyurethane implant for persistent knee pain after partial meniscectomy with a minimum of two years follow-up

Objetivo. Evaluar los resultados de un implante de poliuretano en 10 pacientes con dolor persistente tras meniscectomía parcial. Material y métodos. Estudio prospectivo descriptivo de 10 pacientes que fueron intervenidos para colocación artroscópica de un implante meniscal de poliuretano. Se realizó evaluación funcional, de resonancia magnética y radiología simple antes de la intervención, a los 6 meses, un año, y en el seguimiento final con un mínimo de dos años. La evaluación clínica incluyó las escalas de Lysholm, KOOS y EVA. En resonancia magnética (RM) se evaluó la morfología y la intensidad de la señal del implante según los criterios de Genovese et al. Resultados. Se encontraron diferencias significativas entre la media de puntuación de Lysholm antes de la cirugía (63,5 puntos), a los 6 meses (76,8 puntos) (p = 0,001), al año (83,3 puntos) (p < 0,001) y al final del seguimiento (84,4 puntos) (p < 0,001). En la puntuación del KOOS se hallaron diferencias significativas entre las medias en el preoperatorio (64,23 puntos) y 6 meses (73,66 puntos) (p = 0,001), un año (81,39 puntos) (p < 0,001) y el seguimiento final (83,34 puntos) (p < 0,001). Los valores promedio de la EVA fueron de 5,7 puntos en el preoperatorio, 3,6 puntos a los 6 meses (p < 0,001), 1,9 puntos al año (p < 0,001) y 1,9 puntos al final del seguimiento (p < 0,001). La radiología mostró cambios degenerativos en un caso. En la RM, el tamaño del implante y la intensidad de la señal de RM disminuyeron progresivamente, no llegando a alcanzar nunca los de un menisco normal. Conclusiones. Veinticuatro meses después de la cirugía se ha encontrado una mejora significativa en todos los parámetros clínicos, salvo en un paciente que precisó reintervención. El tamaño del implante se redujo y en ningún caso se alcanzó una imagen de RM similar a la de un menisco normal. El procedimiento demostró ser seguro y útil para el tratamiento del dolor persistente tras meniscectomía (AU)

Purpose. To present the results of a polyurethane meniscal scaffold implant in 10 patients with persistent pain after meniscectomy. Methods. Prospective, descriptive study of ten patients who underwent arthroscopic implantation of a polyurethane meniscal scaffold. Functional, MRI, and radiography assessment was performed pre-operatively and at 6-months, 1-year, and a final follow-up at a minimum of two years. Clinical evaluation included Lysholm score, KOOS and VAS. The MRI morphology and signal intensity of the implant were evaluated according to the criteria of Genovese et al. Results. Statistically significant differences were found between the mean Lysholm score before surgery (63.5 points), and that at 6 months (76.8 points) (p = .001), one year (83.3 points) (p < .001) and final follow-up (84.4 points) (p < .001). KOOS showed significant differences between before surgery (64.23 points), 6 months (73.66 points) (p = .001), one year (81.39 points) (p < .001) and final follow-up (83.34 points) (p < .001). The mean values for VAS were 5.7 points in the pre-operative evaluation, 3.6 points at 6 months-follow-up (p < .001), 1.9 points at one year (p < .001), and 1.9 points at final follow-up (p < .001). Radiology showed degenerative changes in one case. In MRI, the size of the implant and the intensity of the MRI signal gradually decreased, but it never changed to that of a normal meniscus. Conclusion. A significant improvement was found in all the clinical parameters 24 months after the surgery, except in one patient who underwent furher surgery. The scaffold reduced its size and but never achieved an MRI image similar to that of a normal meniscus (AU)

The procedure proved to be safe and useful for the treatment of persistent pain after meniscectomy (AU)